Exact Mass: 409.0385

Exact Mass Matches: 409.0385

Found 74 metabolites which its exact mass value is equals to given mass value 409.0385, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Glucotropaeolin

{[(E)-(2-phenyl-1-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}ethylidene)amino]oxy}sulfonic acid

C14H19NO9S2 (409.0501)


Glucotropeolin belongs to the class of organic compounds known as alkylglucosinolates. These are organic compounds containing a glucosinolate moiety that carries an alkyl chain. Outside of the human body, glucotropaeolin has been detected, but not quantified in, several different foods, such as white mustards, garden cress, horseradish, cabbages, and Brassicas. This could make glucotropaeolin a potential biomarker for the consumption of these foods. Glucotropaeolin is isolated from seeds of Tropaeolum majus (garden nasturtium), Lepidium sativum (garden cress), and other crucifers. Isolated from seeds of Tropaeolum majus (garden nasturtium), Lepidium sativum (garden cress) and other crucifers. Glucotropaeolin is found in many foods, some of which are brassicas, horseradish, papaya, and white mustard. Acquisition and generation of the data is financially supported in part by CREST/JST.

   

Lifibrate

1-Methylpiperidin-4-yl 2,2-bis(4-chlorophenoxy)acetic acid

C20H21Cl2NO4 (409.0848)


C78276 - Agent Affecting Digestive System or Metabolism > C29703 - Antilipidemic Agent > C98150 - Fibrate Antilipidemic Agent

   

methionine aspartate aspartate

4,11-diamino-3,6,9,12-tetraoxo-1,2,7,8-tetraoxacyclododecan-4-yl 2-amino-4-(methylsulfanyl)butanoate

C13H19N3O10S (409.0791)


   

Disodium guanylate

disodium {[5-(2-amino-6-oxo-6,9-dihydro-1H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}phosphonic acid

C10H14N5Na2O8P (409.0375)


Flavour enhancer. As it is a fairly expensive additive, it is not used independently of glutamic acid; if disodium guanylate is present in a list of ingredients but MSG does not appear to be, it is likely that glutamic acid is provided as part of another ingredient such as a processed soy protein complex. It is often added to foods in conjunction with disodium inosinate; the combination is known as disodium 5-ribonucleotides.; Disodium guanylate (E627), also known as sodium 5-guanylate and disodium 5-guanylate, is the disodium salt of the flavor enhancer guanosine monophosphate (GMP). Disodium guanylate is a food additive and is commonly used in conjunction with glutamic acid (monosodium glutamate, MSG). Flavour enhancer

   
   

2-Methylsulfinylethyl glucosinolate

2-Methylsulfinylethyl glucosinolate

C10H19NO10S3 (409.0171)


   
   
   

cladoniamide D

cladoniamide D

C21H16ClN3O4 (409.0829)


An organic heteropentacyclic compound that is cladoniamide E in which the chlorine attached to the methoxy-bearing indole moiety is replaced by a hydrogen. It has been isolated from the culture broth of Streptomyces uncialis.

   
   

cladoniamide F

cladoniamide F

C21H16ClN3O4 (409.0829)


An organic heteropentacyclic compound that is cladoniamide G in which the chlorine attached to the methoxy-bearing indole moiety is replaced by a hydrogen. It has been isolated from the culture broth of Streptomyces uncialis.

   
   
   

Benzylglucosinolate

Benzylglucosinolate

C14H19NO9S2 (409.0501)


   

Benzyl Glucotropaeolin

Benzyl Glucotropaeolin

C14H19NO9S2 (409.0501)


   

Benzyl glucosinolate

Benzyl glucosinolate

C14H19NO9S2 (409.0501)


Annotation level-1

   

2-(3-Iodo-2-(phenylselanyl)phenyl)-4,4-dimethyl-4,5-dihydrooxazole

2-(3-Iodo-2-(phenylselanyl)phenyl)-4,4-dimethyl-4,5-dihydrooxazole

C17H16INOS (408.9997)


   

Diloxanide-O-Glucuronide

Diloxanide-O-Glucuronide

C15H17Cl2NO8 (409.0331)


   

(R)-2-Benzyloxycarbonylamino-1,5-dimethanesulfonyloxypentane

(R)-2-Benzyloxycarbonylamino-1,5-dimethanesulfonyloxypentane

C15H23NO8S2 (409.0865)


   

Tiquizium bromide

Tiquizium bromide

C19H24BrNS2 (409.0533)


C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent

   

2-Deoxycytidine-5-diphosphate trisodium salt

2-Deoxycytidine-5-diphosphate trisodium salt

C9H14N3NaO10P2 (409.0052)


   

3-[(4-Methyl-3-nitrophenyl)sulfonyl]-2-(3-nitrophenyl)-1,3-thiazo lidine

3-[(4-Methyl-3-nitrophenyl)sulfonyl]-2-(3-nitrophenyl)-1,3-thiazo lidine

C16H15N3O6S2 (409.0402)


   

Neodymium acetate hydrate (1:3:5)

Neodymium acetate hydrate (1:3:5)

C6H19NdO11 (409.0005)


   

2-CHLORO-5-(TRIBUTYLSTANNYL)-1,3-THIAZOLE

2-CHLORO-5-(TRIBUTYLSTANNYL)-1,3-THIAZOLE

C15H28ClNSSn (409.0653)


   

6-BROMOSPIRO[CHROMENE-2,4-PIPERIDIN]-4(3H)-ONE TRIFLUOROACETATE

6-BROMOSPIRO[CHROMENE-2,4-PIPERIDIN]-4(3H)-ONE TRIFLUOROACETATE

C15H15BrF3NO4 (409.0136)


   
   

5-Chloro-N-[(2R)-2-hydroxy-3-[[4-(3-oxo-4-morpholinyl)phenyl]amino]propyl]-2-thiophenecarboxamide

5-Chloro-N-[(2R)-2-hydroxy-3-[[4-(3-oxo-4-morpholinyl)phenyl]amino]propyl]-2-thiophenecarboxamide

C18H20ClN3O4S (409.0863)


   

5-methyl-3-(methylthio)-1,4-diphenyl-1h-1,2,4-triazolium iodide

5-methyl-3-(methylthio)-1,4-diphenyl-1h-1,2,4-triazolium iodide

C16H16IN3S (409.011)


   

6-Bromo-1H-spiro[piperidine-4,2-quinazolin]-4(3H)-one triflu oroacetate (1:1)

6-Bromo-1H-spiro[piperidine-4,2-quinazolin]-4(3H)-one triflu oroacetate (1:1)

C14H15BrF3N3O3 (409.0249)


   

4-CHLORO-3-[[[[(2-NITROPHENOXY)ACETYL]AMINO]THIOXOMETHYL]AMINO]-BENZOIC ACID

4-CHLORO-3-[[[[(2-NITROPHENOXY)ACETYL]AMINO]THIOXOMETHYL]AMINO]-BENZOIC ACID

C16H12ClN3O6S (409.0135)


   

bis(acetato-O)(7-chloro-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylato-O(3),O(4))boron

bis(acetato-O)(7-chloro-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylato-O(3),O(4))boron

C17H14BClFNO7 (409.0536)


   

5-iodoacetamido-5-deoxythymidine

5-iodoacetamido-5-deoxythymidine

C12H16IN3O5 (409.0135)


   

sodium 2-[4-(2-cyanoacetamido)phenyl]-6-methylbenzothiazole-7-sulphonate

sodium 2-[4-(2-cyanoacetamido)phenyl]-6-methylbenzothiazole-7-sulphonate

C17H12N3NaO4S2 (409.0167)


   

H-Gly-Pro-AMC · HBr

H-Gly-Pro-AMC · HBr

C17H20BrN3O4 (409.0637)


   

dimethylsilyl (t-butylamido) tetramethylcyclopentadienyl zirconium dichloride

dimethylsilyl (t-butylamido) tetramethylcyclopentadienyl zirconium dichloride

C15H27Cl2NSiZr (409.0337)


   
   

Fanapanel

Fanapanel

C14H15F3N3O6P (409.0651)


C26170 - Protective Agent > C1509 - Neuroprotective Agent Fanapanel (ZK200775) is a highly selective AMPA/kainate antagonist with little activity against NMDA; have Ki values of 3.2 nM, 100 nM, and 8.5 μM against quisqualate, kainate, and NMDA, respectively.

   

3-chloro-5-[2-chloro-5-(1H-indazol-3-ylmethoxy)phenoxy]benzonitrile

3-chloro-5-[2-chloro-5-(1H-indazol-3-ylmethoxy)phenoxy]benzonitrile

C21H13Cl2N3O2 (409.0385)


   

Nedocromil calcium

Nedocromil calcium

C19H15CaNO7 (409.0474)


C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D000893 - Anti-Inflammatory Agents > D000082142 - Mast Cell Stabilizers D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents D018926 - Anti-Allergic Agents D007155 - Immunologic Factors

   

Tyrosine-4-azobenzenearsonate

Tyrosine-4-azobenzenearsonate

C15H16AsN3O6 (409.0255)


An L-tyrosine derivative having a 4-arsonophenyldiazenyl group at the 3-position of the benzene ring.

   

3-[5-[(4-Chlorophenyl)methylthio]-1,3,4-oxadiazol-2-yl]-1-(phenylmethyl)-2-pyridinone

3-[5-[(4-Chlorophenyl)methylthio]-1,3,4-oxadiazol-2-yl]-1-(phenylmethyl)-2-pyridinone

C21H16ClN3O2S (409.0652)


   

3-[(4-Bromophenyl)amino]-3-(4-methoxyphenyl)-1-phenylpropan-1-one

3-[(4-Bromophenyl)amino]-3-(4-methoxyphenyl)-1-phenylpropan-1-one

C22H20BrNO2 (409.0677)


   

3-((3-Bromo-5-O-Tolylpyrazolo[1,5-A]pyrimidin-7-Ylamino)methyl)pyridine 1-Oxide

3-((3-Bromo-5-O-Tolylpyrazolo[1,5-A]pyrimidin-7-Ylamino)methyl)pyridine 1-Oxide

C19H16BrN5O (409.0538)


   

lifibrate

lifibrate

C20H21Cl2NO4 (409.0848)


C78276 - Agent Affecting Digestive System or Metabolism > C29703 - Antilipidemic Agent > C98150 - Fibrate Antilipidemic Agent

   

Deoxyinosine diphosphate

Deoxyinosine diphosphate

C10H11N4O10P2-3 (408.995)


COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

Glucotropeolin

Glucotropeolin

C14H19NO9S2 (409.0501)


An aralkylglucosinolic acid that consists of 1-thio-beta-D-glucopyranose attached to a 2-phenyl-N-(sulfooxy)ethanimidoyl group at the anomeric sulfur.

   

disodium;[5-(2-amino-6-oxo-1H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate

disodium;[5-(2-amino-6-oxo-1H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate

C10H14N5Na2O8P+2 (409.0375)


   

Adenosine-5-phosphate-2,3-cyclic phosphate

Adenosine-5-phosphate-2,3-cyclic phosphate

C10H13N5O9P2 (409.0189)


   

(E)-3-(1,3-benzothiazol-2-yl)-4-(5-chloro-3-methyl-1-phenylpyrazol-4-yl)but-3-enoic acid

(E)-3-(1,3-benzothiazol-2-yl)-4-(5-chloro-3-methyl-1-phenylpyrazol-4-yl)but-3-enoic acid

C21H16ClN3O2S (409.0652)


   

N-(1,3-benzodioxol-5-yl)-2-[(8-methoxy-5H-[1,2,4]triazino[5,6-b]indol-3-yl)thio]acetamide

N-(1,3-benzodioxol-5-yl)-2-[(8-methoxy-5H-[1,2,4]triazino[5,6-b]indol-3-yl)thio]acetamide

C19H15N5O4S (409.0845)


   

5-Bromo-2-(4-(tert-butyl)benzamido)-4-chlorobenzoic acid

5-Bromo-2-(4-(tert-butyl)benzamido)-4-chlorobenzoic acid

C18H17BrClNO3 (409.008)


   

1-(3-chloro-4-methoxyphenyl)sulfonyl-N-(3-pyridinyl)-3-piperidinecarboxamide

1-(3-chloro-4-methoxyphenyl)sulfonyl-N-(3-pyridinyl)-3-piperidinecarboxamide

C18H20ClN3O4S (409.0863)


   

N-(2,4-dichlorophenyl)-2-[[5-(2-methoxyphenyl)-1,3,4-oxadiazol-2-yl]thio]acetamide

N-(2,4-dichlorophenyl)-2-[[5-(2-methoxyphenyl)-1,3,4-oxadiazol-2-yl]thio]acetamide

C17H13Cl2N3O3S (409.0055)


   

5-bromo-N-[3-(2-oxo-1-benzopyran-3-yl)phenyl]-2-furancarboxamide

5-bromo-N-[3-(2-oxo-1-benzopyran-3-yl)phenyl]-2-furancarboxamide

C20H12BrNO4 (408.995)


   

{[(E)-(2-phenyl-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}ethylidene)amino]oxy}sulfonic acid

{[(E)-(2-phenyl-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}ethylidene)amino]oxy}sulfonic acid

C14H19NO9S2 (409.0501)


   

2-deoxyinosine 5-diphosphate(3-)

2-deoxyinosine 5-diphosphate(3-)

C10H11N4O10P2 (408.995)


A 2-deoxyribonucleoside 5-diphosphate obtained by deprotonation of the diphosphate OH groups of 2-deoxyinosine 5-diphosphate; major species at pH 7.3.

   

AT7867 (dihydrochloride)

AT7867 (dihydrochloride)

C20H22Cl3N3 (409.0879)


AT7867 dihydrochloride is a potent ATP-competitive inhibitor of Akt1/Akt2/Akt3 and p70S6K/PKA with IC50s of 32 nM/17 nM/47 nM and 85 nM/20 nM, respectively.

   

Azemiglitazone (potassium)

Azemiglitazone (potassium)

C19H16KNO5S (409.0386)


Azemiglitazone potassium (MSDC-0602K), a PPARγ-sparing thiazolidinedione (Ps-TZD), binds to PPARγ with the IC50 of 18.25 μM[1]. Azemiglitazone potassium modulates the mitochondrial pyruvate carrier (MPC). Azemiglitazone potassium can be used for the research of fatty liver including dysfunctional lipid metabolism, inflammation, and insulin resistance[2]. Azemiglitazone potassium, an insulin sensitizer, improves insulinemia and fatty liver disease in mice, alone and in combination with Liraglutide[3].

   

MMRi64

MMRi64

C22H17Cl2N3O (409.0749)


MMRi64 disrupts Mdm2-MdmX interactions. MMRi64 downregulates Mdm2 and MdmX in leukemia cells. MMRi64 induces p53 accumulation, and induces the apoptotic arm of the p53 pathway in leukemia/lymphoma cells. MMRi64 can be used for cancer research[1].

   

SKF-82958 (hydrobromide)

SKF-82958 (hydrobromide)

C19H21BrClNO2 (409.0444)


SKF-82958 ((±)-SKF 82958) hydrobromide is a dopamine D1 receptor full agonist (K0.5=4 nM), displays selective for D1 over D2 receptors (K0.5=73 nM). SKF-82958 hydrobromide induces dopamine D1 receptor-dependent adenylate cyclase activity in rat striatal membranes (EC50=491 nM)[1].

   

SR17018

SR17018

C19H18Cl3N3O (409.0515)


SR17018 is an mu-opioid-receptor (MOR) agonist, binding with GTPγS, with an EC50 of 97 nM.

   

n-{3-[(4s)-1-[(1e)-2-(3-bromo-4-methoxyphenyl)ethenyl]-2-hydroxy-5-oxo-4h-imidazol-4-yl]propyl}guanidine

n-{3-[(4s)-1-[(1e)-2-(3-bromo-4-methoxyphenyl)ethenyl]-2-hydroxy-5-oxo-4h-imidazol-4-yl]propyl}guanidine

C16H20BrN5O3 (409.0749)


   

(11r)-7-chloro-11-hydroxy-20-methoxy-n-methyl-12-oxo-3,13-diazapentacyclo[11.7.0.0²,¹⁰.0⁴,⁹.0¹⁴,¹⁹]icosa-1(20),2(10),4,6,8,14,16,18-octaene-11-carboximidic acid

(11r)-7-chloro-11-hydroxy-20-methoxy-n-methyl-12-oxo-3,13-diazapentacyclo[11.7.0.0²,¹⁰.0⁴,⁹.0¹⁴,¹⁹]icosa-1(20),2(10),4,6,8,14,16,18-octaene-11-carboximidic acid

C21H16ClN3O4 (409.0829)


   

7-chloro-11-hydroxy-20-methoxy-n-methyl-12-oxo-3,13-diazapentacyclo[11.7.0.0²,¹⁰.0⁴,⁹.0¹⁴,¹⁹]icosa-1(20),2(10),4,6,8,14,16,18-octaene-11-carboximidic acid

7-chloro-11-hydroxy-20-methoxy-n-methyl-12-oxo-3,13-diazapentacyclo[11.7.0.0²,¹⁰.0⁴,⁹.0¹⁴,¹⁹]icosa-1(20),2(10),4,6,8,14,16,18-octaene-11-carboximidic acid

C21H16ClN3O4 (409.0829)


   

(2r)-3-{[(1-hydroxy-3,6-dimethoxy-5,8-dioxonaphthalen-2-yl)methyl]sulfanyl}-2-[(1-hydroxyethylidene)amino]propanoic acid

(2r)-3-{[(1-hydroxy-3,6-dimethoxy-5,8-dioxonaphthalen-2-yl)methyl]sulfanyl}-2-[(1-hydroxyethylidene)amino]propanoic acid

C18H19NO8S (409.0831)


   

(2r)-3-({[1-hydroxy-7-(hydroxymethyl)-3-methoxy-5,8-dioxonaphthalen-2-yl]methyl}sulfanyl)-2-[(1-hydroxyethylidene)amino]propanoic acid

(2r)-3-({[1-hydroxy-7-(hydroxymethyl)-3-methoxy-5,8-dioxonaphthalen-2-yl]methyl}sulfanyl)-2-[(1-hydroxyethylidene)amino]propanoic acid

C18H19NO8S (409.0831)


   

7-chloro-12-hydroxy-20-methoxy-n-methyl-11-oxo-3,13-diazapentacyclo[11.7.0.0²,¹⁰.0⁴,⁹.0¹⁴,¹⁹]icosa-1(20),2(10),4,6,8,14,16,18-octaene-12-carboximidic acid

7-chloro-12-hydroxy-20-methoxy-n-methyl-11-oxo-3,13-diazapentacyclo[11.7.0.0²,¹⁰.0⁴,⁹.0¹⁴,¹⁹]icosa-1(20),2(10),4,6,8,14,16,18-octaene-12-carboximidic acid

C21H16ClN3O4 (409.0829)


   

n-(3-{1-[(1e)-2-(3-bromo-4-methoxyphenyl)ethenyl]-2-hydroxy-5-oxo-4h-imidazol-4-yl}propyl)guanidine

n-(3-{1-[(1e)-2-(3-bromo-4-methoxyphenyl)ethenyl]-2-hydroxy-5-oxo-4h-imidazol-4-yl}propyl)guanidine

C16H20BrN5O3 (409.0749)


   

[(2-phenyl-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}ethylidene)amino]oxysulfonic acid

[(2-phenyl-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}ethylidene)amino]oxysulfonic acid

C14H19NO9S2 (409.0501)


   

(2r)-3-{[(1,3-dihydroxy-6-methoxy-7-methyl-5,8-dioxonaphthalen-2-yl)methyl]sulfanyl}-2-[(1-hydroxyethylidene)amino]propanoic acid

(2r)-3-{[(1,3-dihydroxy-6-methoxy-7-methyl-5,8-dioxonaphthalen-2-yl)methyl]sulfanyl}-2-[(1-hydroxyethylidene)amino]propanoic acid

C18H19NO8S (409.0831)


   

(12s)-7-chloro-12-hydroxy-20-methoxy-n-methyl-11-oxo-3,13-diazapentacyclo[11.7.0.0²,¹⁰.0⁴,⁹.0¹⁴,¹⁹]icosa-1(20),2(10),4,6,8,14,16,18-octaene-12-carboximidic acid

(12s)-7-chloro-12-hydroxy-20-methoxy-n-methyl-11-oxo-3,13-diazapentacyclo[11.7.0.0²,¹⁰.0⁴,⁹.0¹⁴,¹⁹]icosa-1(20),2(10),4,6,8,14,16,18-octaene-12-carboximidic acid

C21H16ClN3O4 (409.0829)


   

[(z)-(2-phenyl-1-{[(2r,3s,4r,5r,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}ethylidene)amino]oxysulfonic acid

[(z)-(2-phenyl-1-{[(2r,3s,4r,5r,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}ethylidene)amino]oxysulfonic acid

C14H19NO9S2 (409.0501)


   

n-(3-{1-[2-(3-bromo-4-methoxyphenyl)ethenyl]-2-hydroxy-5-oxo-4h-imidazol-4-yl}propyl)guanidine

n-(3-{1-[2-(3-bromo-4-methoxyphenyl)ethenyl]-2-hydroxy-5-oxo-4h-imidazol-4-yl}propyl)guanidine

C16H20BrN5O3 (409.0749)